Sandy Zweifach

Biography

Sanford Zweifach has 25 years' experience in the life sciences industry, with extensive background in corporate partnering, business development, operations, P&L, private and public investing, and capital raising. He is the Founder and Chief Executive Officer of Nuvelution Pharma, Inc. Previously, Mr. Zweifach served as CEO of Ascendancy Healthcare, Inc., which he also founded, and before this, he was a Partner at Reedland Capital Partners, a boutique investment bank, where he headed its life sciences M&A and advisory efforts. Prior to this, he was CEO of Pathways Diagnostics, a biomarker development company. Previously, Mr. Zweifach was Chief Financial Officer and Managing Director of Bay City Capital, a merchant bank specializing in the biotech and the life science industry, where he was responsible for oversight of the firm's finance department, as well as President of the firm's M&A and financing division. Prior to this, he was President and CFO of Epoch Biosciences, which was acquired by Nanogen in 2004. Currently, he is a director of Anthera Pharmaceuticals, Lyric Pharmaceuticals, and Viventia Bio. Earlier in his career, Mr. Zweifach was a Certified Public Accountant for Coopers & Lybrand and held various investment banking positions focusing on biotech. He received his BA in Biology from UC San Diego and his MS in Human Physiology from UC Davis. 

Research Interest

 Pharmaceuticals